Cardioloxía
Servicio
University of Amsterdam
Ámsterdam, HolandaPublicacións en colaboración con investigadores/as de University of Amsterdam (36)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
-
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Diabetes Research and Clinical Practice, Vol. 203
-
Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis
International Journal of Cardiology
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891
2021
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
2020
-
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study
Atherosclerosis, Vol. 295, pp. 45-53
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five-year clinical outcomes of the randomised ABSORB II trial
EuroIntervention, Vol. 16, Núm. 11, pp. E938-E941
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269
-
Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
Atherosclerosis, Vol. 312, pp. 79-89
-
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction
Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
-
The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study
International Journal of Cardiology, Vol. 318, pp. 1-6